The safety of escitalopram during pregnancy and breastfeeding: A comprehensive review

Human Psychopharmacology

Volumn 27, Issue 6, 2012, Pages 534-539

  Bellantuono, Cesario ^a   Bozzi, Francesca ^a   Orsolini, Laura ^a   Catena Dell'Osso, Mario ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

breastfeeding; escitalopram; major malformations; perinatal complications; pregnancy; selective serotonin reuptake inhibitors (SSRIs)

Indexed keywords

ESCITALOPRAM;

BREAST FEEDING; CONGENITAL MALFORMATION; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG MILK LEVEL; DRUG SAFETY; FIRST TRIMESTER PREGNANCY; HUMAN; LOW BIRTH WEIGHT; NECROTIZING ENTEROCOLITIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; SECOND TRIMESTER PREGNANCY; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

ABNORMALITIES, DRUG-INDUCED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BREAST FEEDING; CITALOPRAM; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; INFANT, NEWBORN; LACTATION; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; SEROTONIN UPTAKE INHIBITORS;

EID: 84868536893     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2265     Document Type: Review

References (49)

1. ACOG, Committee on Practice Bulletins-Obstetrics. 2008. ACOG practice bullettin: clinical management guidelines for ostetricics-gynecologists, 92, April 2008 (replaces practice bulletin number 87, November 2007): use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 111 (4): 1001-1020.
2. Alwan S, Friedman JM,. 2009. Safety of selective serotonin reuptake inhibitors in pregnancy. CNS Drugs 23 (6): 493-509.
3. Alwan S, Reefhuis J, Rasmussen SA, Friedman JM,. 2011. National birth defects prevention study. Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol 51 (2): 264-270.
4. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, fourth edn. American Psychiatric Association: Washington, DC.
5. Bancalari E, Claure N, Gonzales A,. 2005. Patent ductus arteriosus and respiratory outcome in premature infants. Biol Neonate 88 (3): 192-201.
6. Baskin LS, Ebbers MB,. 2006. Hypospadias: anatomy, etiology, and technique. J Pediatr Surg 41 (3): 463-472.
7. Borri C, Mauri M, Oppo A, et al,. 2008. Axis I psychopathology and functional impairment at the third month of pregnancy: results from the perinatal depression-research and screening unit (PND-ReScU) study. J Clin Psychiatry 69 (10): 1617-1624.
8. Castberg I, Spigset O,. 2006. Excretion of escitalopram in breast milk. J Clin Psychopharmacol 26 (5): 536-538.
9. Cipriani A, Furukawa TA, Salanti G, et al,. 2009. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373 (9665): 746-758.
10. Cooper WO, Willy ME, Pont SJ, Ray WA,. 2007. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 196 (6): 544. e1-5.
11. Corbett HJ, Losty PD,. 2009. Congenital diaphragmatic hernia. In Pediatric Thoracic Surgery, Rich DH, Crabbe DC, Auldist AW, Rothenberg SS, (eds). Springer-Verlag: London; 483-499.
12. Davalos DB, Yadon CA, Tregellas HC,. 2012. Untreated prenatal maternal depression and the potential risks to offspring: a review. Arch Womens Ment Health 15 (1): 1-14.
13. Davis EP, Glynn LM, Dunkel Schetter C, Hobel C, Chicz-Demet A, Sandman CA,. 2007. Prenatal exposure to prenatal depression and cortisol influences infant temperament. J Am Acad Child Adolesc Psychiatry 46 (6): 737-746.
14. Diav-Citrin O, Ornoy A,. 2012. Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat? Obstet Gynecol Int 2012: 698947 Epub 2011 Dec 10.
15. Djakovic N, Nyarangi-Dix J, Ozturk A, Hohenfellner M,. 2008. Hypospadias. Adv Urol 2008: 650135.
16. Eberhard-Gran M, Eskild A, Opiordsmoen S,. 2006. Use of psychotropic medications in treating mood disorders during lactation: practical recommendations. CNS Drugs 20 (3): 187-198.
17. Einarson A, Choi J, Einarson TR, Koren G,. 2009. Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry 54 (4): 242-246.
18. Evans J, Heron J, Francomb H, Oke S, Golding J,. 2001. Cohort study of depressed mood during pregnancy and after childbirth. BMJ 323 (7307): 257-260.
19. Gentile S,. 2005. SSRIs in pregnancy and lactation: emphasis on neurodevelopmental outcome. CNS Drugs 19 (7): 623-633.
20. Gentile S,. 2006. Escitalopram late in pregnancy and while breast-feeding. Ann Pharmacother 40 (9): 1696-1697.
21. Gentile S,. 2007. Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf 30 (2): 107-121.
22. Gentile S,. 2008. Use of escitalopram during pregnancy navigating towards international guidelines and the real world. Clin Drug Invest 28 (11): 735-739.
23. Gentile S,. 2010. On categorizing gestational, birth, and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome. CNS Spectr 15 (3): 167-185.
24. Gentile S,. 2011. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects. Acta Psychiatr Scand 123: 266-275.
25. Gentile S, Bellantuono C,. 2009. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine. J Clin Psychiatry 70 (3): 414-422.
26. Grant BF, Goldstein RB, Chou SP, et al,. 2009. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the wave 2 national epidemiologic survey on alcohol and related conditions. Mol Psychiatry 14 (11): 1051-1066.
27. Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WJ,. 2010. A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight and intrauterine growth restriction. Arch Gen Psychiatry 67 (10): 1012-1024.
28. Grzeskowiak LE, Gilbert AL, Morrison JL,. 2011. Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues. Drug Saf 34 (11): 1027-1048.
29. Gurbaz MT, Kazez A, Bakal U, Tartar T, Ersoz F, Colakoglu Y,. 2012. Congenital diaphragmatic hernia in identical twins. J Indian Assoc Pediatr Surg 17 (1): 26-27.
30. Ilett KF, Hackett LP, Kristensen JH, Rampono J, Kohan R,. 2005. Estimation of infant dose and assessment of breastfeeding safety for escitalopram use in postnatal depression. Ther Drug Monit 27 (2): 248.
31. Kallen BA, Otterblad OP,. 2007. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 79 (4): 301-308.
32. Kendall-Tackett K, Hale TW,. 2010. The use of antidepressants in pregnant and breastfeeding women: a review of recent studies. J Human Lact 26 (2): 187-195.
33. Kim MG, Chung WJ, Choi CH, et al,. 2011. Right coronary cusp prolapse resembling subpulmonic stenosis in an old adult patient with ventricular septal defect. J Cardiovasc Ultrasound 19 (4): 216-220.
34. Klieger-Grossmann C, Weitzner B, Panchaud A, et al,. 2012. Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. J Clin Pharmacol 52 (5): 766-770.
35. Lattimore KA, Donn SM, Kaciroti N, Kemper AR, Neal CR, Jr, Vazquez DM,. 2005. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol 25 (9): 595-604.
36. Majewski S, Donnenfeld AE, Kuhlman K, Patel A,. 2007. Second-trimester prenatal diagnosis of total arhinia. J Ultrasound Med 26 (3): 391-395.
37. Malm H, Artama M, Gissler M, Ritvanen A,. 2011. Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol 118 (1): 111-120.
38. Medina MJ,. 2011. Description of a case presents in the previous issue. Patient ductus arteriosus. Arch Argent Pediatr 109 (6): 545-547.
39. Potts AL, Young KL, Carter BS, Shenai JP,. 2007. Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective-serotonin reuptake inhibitor, escitalopram. J Perinatol 27 (2): 120-122.
40. Rampono J, Hackett LP, Kristensen JH, Kohan R, Page-Sharp M, Ilett KF,. 2006. Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk. Br J Clin Pharmacol 62 (3): 316-322.
41. Rampono J, Simmer K, Ilett KF, et al,. 2009. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry 42 (3): 95-100.
42. Stewart DE,. 2011. Clinical practice. Depression during pregnancy. N Engl J Med 365 (17): 1605-1611.
43. Thompson AM, Bizzarro MJ,. 2008. Necrotizing enterocolitis in newborns: pathogenesis, prevention and management. Drugs 68 (9): 1227-1238.
44. Tixier H, Feyeux C, Girod S, et al,. 2008. Acute voluntary intoxication with selective serotonin reuptake inhibitors during the third trimester of pregnancy: therapeutic management of mother and fetus. Am J Obstet Gynecol 199 (5): e9-e12.
45. Webb GD, Smallhorn JF, Therrien J, Redington AN,. 2011. Congenital heart disease. In Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 9th edn, Bonow RO, Mann DL, Zipes DP, Libby P, (eds). Saunders Elsevier: Philadelphia, Pa. chap 65.
46. WHO. 2010. Data and Statistics. World Health Organization: Geneva. www.who.int/research/en.
47. Wichman CL, Moore KM, Lang TR, St Sauver JL, Heise RH, Jr, Watson WJ,. 2009. Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. Mayo Clin Proc 84 (1): 23-27.
48. Yaris F, Ulku C, Kesim M, et al,. 2005. Psychotropic drugs in pregnancy: a case-control study. Prog Neuropsychopharmacol Biol Psychiatry 29 (2): 333-338.
49. Yonkers KA, Wisner KL, Stewart DE, et al,. 2009. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry 31 (5): 403-413.